GLUCONORM VG2

GLUCONORM VG2 15S is a medication tailored for adults dealing with Type 2 Diabetes Mellitus, particularly when standard treatments, like lifestyle changes or other medications, do not sufficiently regulate blood glucose levels. This formulation employs a tri-layer mechanism designed to maintain impactful and long-lasting glycemic control. The inclusion of 2mg of Glimepiride in this product is significant as it enhances insulin secretion effectively. By reducing both fasting and meal-related blood sugar spikes, GLUCONORM VG2 15S assists in promoting better overall insulin sensitivity and reducing glucose output by the liver. Furthermore, it meticulously manages the digestion and absorption of carbohydrates from food. By ensuring a more stable blood glucose level, this medication is instrumental in mitigating the risk of diabetes-related complications, including kidney disease, visual impairment, nerve issues, foot problems, and serious cardiovascular events. The advanced composition of GLUCONORM VG2 15S is a blend of Glimepiride, Metformin, and Voglibose, each contributing to a comprehensive strategy for blood sugar management. Glimepiride actively boosts insulin production, Metformin enhances the body’s sensitivity to insulin while decreasing glucose production by the liver, and Voglibose effectively slows carbohydrate absorption in the intestine. This synergistic approach is aimed at establishing optimal control over blood glucose, ensuring a healthier lifestyle for those affected by Type 2 Diabetes Mellitus.